Nahid A. Qushmaq: MicroRNAs as Prognostic Biomarkers in Septic Patients
Nahid A. Qushmaq, General Supervisor Assistant for Medical Support Services, Consultant Adult Hematology of Thrombosis and Hemostasis, Head Of Research and Development Department at King Abdullah Medical Complex – Jeddah, shared May AlMoshary’s post on LinkedIn:
”Happy and proud to share our new publication with my esteemed colleagues:
‘Prognostic Value of MicroRNA Profile in Septic Patients with Rare Hereditary Anemias: Insights from a Longitudinal Cohort Study.’
Grateful for the collaboration and dedication behind this work.”
May AlMoshary, Cheif medical executive at Private company, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in International Journal of General Medicine, adding:
”I’m happy to share that our paper is now available online in the International Journal of General Medicine.
This study explores the potential role of miR-155 as a diagnostic and prognostic biomarker in patients with rare hereditary anemias presenting with sepsis, with promising findings for its future use in personalized and miRNA-based therapeutic approaches.
Grateful to all co-authors and colleagues who contributed to this work.”
Title: Prognostic Value of MicroRNA Profiles in Septic Patients with Rare Hereditary Anemias: Insights from a Longitudinal Cohort Study
Authors: May AlMoshary, Nahid Abdulhamid Qushmaq, Abba Elgujja, Abdullah Mikki Alamoudi, Maha Abuhatlah AlQahtani, Hind Bugshan, Marytonia Valiyaveettil Antony, Fatimah Alshahrani
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 16:02Antonio Sorropago: Major Updates in Structural Heart Interventions
-
Aug 31, 2026, 15:44Andrea Boccatonda: Special Issue on Pulmonary Embolism and Venous Thromboembolism
-
Aug 31, 2026, 15:41Adrien Jossart: Acute Thrombotic Storm Following Single Heparin Bolus
-
Aug 31, 2026, 15:36Bernhard Gerber: Myocardial Platelet Activation Linked to Microvascular Obstruction After STEMI
-
Aug 31, 2026, 15:34Higher Fibrinogen γ′ Linked to Increased Risk of Recurrent Arterial Thrombosis – Journal of Thrombosis and Haemostasis
-
Aug 31, 2026, 15:21Ney Carter Borges: Anticoagulation Versus Antiplatelet Therapy After TAVI ESC 26
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?